Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00483639 · ClinicalTrials.gov registry record
Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer
A clinical trial, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT00483639: Completed study, sponsored by Vanderbilt-Ingram Cancer Center.
NCT00483639 is a clinical trial that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00483639 has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
RATIONALE: Patients who undergo treatment for head and neck cancer may become anxious and avoid contact with other people. Learning how cancer treatment may cause anxiety in patients with head and neck cancer may help improve the quality of life in these patients. PURPOSE: This clinical trial is studying anxiety and avoidance of others in patients previously treated for head and neck cancer.
Primary Outcome
Measured by the Liebowitz Social Anxiety Scale and the Social Phobia and Anxiety Inventory, containing 24 items with each item separately rated for fear as 0 (none), 1 (mild), 2 (moderate) to 3 (severe)and for avoidance behavior as 0 (never), 1 (occasionally), 2 (often), to 3 (usually). Scores are summed with lower values indicating lower levels of social anxiety and avoidance.
Interventions
- PROCEDURE management of therapy complications
- OTHER Medical chart review
- OTHER Liebowitz Social Anxiety Scale and the Social Phobia and Anxiety Inventory
- PROCEDURE Structured Clinical Interview for the Diagnostic and Statistical Manual-IV SCID
- OTHER Functional Assessment of Cancer Therapy-General (FACT-G)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2003-11 |
| Est. Completion | 2008-01 |
What the finished NCT00483639 record still lists
NCT00483639 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which management of therapy complications is the first listed.
NCT00483639 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00483639 about?
NCT00483639 is a clinical study titled "Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer". RATIONALE: Patients who undergo treatment for head and neck cancer may become anxious and avoid contact with other people. Learning how cancer treatment may cause anxiety in patients with head and neck cancer may help improve the quality of life in these patients. PURPOSE: This clinical trial is st...
What is the current status of trial NCT00483639?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2003-11. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00483639?
The interventions under investigation include: management of therapy complications (PROCEDURE), Medical chart review (OTHER), Liebowitz Social Anxiety Scale and the Social Phobia and Anxiety Inventory (OTHER), Structured Clinical Interview for the Diagnostic and Statistical Manual-IV SCID (PROCEDURE), Functional Assessment of Cancer Therapy-General (FACT-G) (OTHER).
Who is sponsoring clinical trial NCT00483639?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia